GT Biopharma Ownership | Who Owns GT Biopharma?

GT Biopharma Ownership Summary

100.00% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.51% of its assets in GT Biopharma shares.

GTBP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	GT Biopharma	-	-	100.00%
Sector	Healthcare Stocks	47.25%	8.01%	44.75%
Industry	Biotech Stocks	45.35%	7.81%	46.83%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Extended Market Index	11.45K	0.51%	1.57K
Vanguard Institutional Extnd Mkt Idx Tr	10.50K	0.47%	-
BlackRock Extended Equity Market K	1.16K	0.05%	-
Fidelity Series Total Market Index	1.15K	0.05%	-
Fidelity Nasdaq Composite Index	1.02K	0.05%	-
Fidelity Total Market Index	992.00	0.04%	-
NT Ext Equity Mkt Idx Fd - NL	604.00	0.03%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	487.00	0.02%	1.00
Spartan Total Market Index Pool E	411.00	0.02%	-
Northern Trust Extended Eq Market Idx	389.00	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 11, 2023	Breen Michael Martin	Executive Chairman/Interim CEO	Buy	$25.00K
Apr 06, 2023	Ohri Manu	CFO & Secretary	Buy	$25.00K
Dec 22, 2020	Wendel Bruce	-	Buy	$12.19K
Nov 16, 2020	Wendel Bruce	-	Buy	$10.26K
Dec 22, 2020	Wendel Bruce	-	Buy	$3.85K

Insider Transactions Trends

Date	Buy	Sell
2023 Q2	2	-
2023 Q1	-	-
2022 Q3	-	-
2022 Q2	-	-
2022 Q1	-	-

GTBP Ownership FAQ

Who Owns GT Biopharma?

GT Biopharma shareholders are primarily institutional investors at 0.00%, followed by 0% insiders and 0% retail investors. The average institutional ownership in GT Biopharma's industry, Biotech Stocks , is 45.35%, which GT Biopharma falls below.

Does Blackrock own GT Biopharma?

BlackRock is not among the top 10 institutional shareholders of GT Biopharma.

Who is the top mutual fund holder of GT Biopharma shares?

Fidelity Extended Market Index is the top mutual fund holder of GT Biopharma shares, with 0.51% of its total shares outstanding invested in 11.45K GT Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools